IGF1 and breast cancer: In breast cancer, ERα/mTOR crosstalk is an important indicator of hormone receptor status, as IGF-mediated mTORC1 activation repressed progesterone receptor (PgR) expression in the ER+/PgR− breast cancer cell phenotype.